Loading stock data…
Serina Therapeutics, Inc. (SER)
$1.95+0.14 (+7.73%)
After Hours$1.97+0.02 (+1.03%)· Last close Jun 29
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Serina Therapeutics, Inc. in the Healthcare sector is trading at $1.95 with a market capitalization of $27M. Wall Street consensus targets $11.00 (1 analysts), implying a +464.1% move over the next 12 months. The stock is currently near its 52-week low of $1.22, remaining 32.5% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +464.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$6.28M↓ | -$6.21M↑ | -$6.39M↓ | -$5.57M↑ | -$5.86M |
| Net Income | -$6.90M↓ | -$3.34M↑ | -$4.58M↑ | -$6.45M↓ | -$4.81M |
Peer Comparison
JNJUNHPFE
Fundamentals
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$26.85M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-120.64%
Volume
Today's trading volume
55,852
Recent News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26% to $6.33. The market value of their outstanding shares is at $963.2 million. The company's, Q1 earnings came out yesterday. Whitehawk Therapeutics (NASDAQ:WHWK) stock rose 20.17% to $4.71. The market value of their outstanding shares is at $193.8 million. As per
Fed Politics Weigh on Investor Sentiment, Driving Muted Premarket Action for US Equity Futures
US equity futures were flat ahead of Tuesday's opening bell after President Donald Trump said he was
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Investors Await Economic Data, Trump Orders to Remove Lisa Cook
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1% and the actively tr